The post ADA26: Kidney disease analysis given spotlight appeared first on Clinical Trials Arena.
ADA26: Kidney disease analysis given spotlight
Study data, including real-world analysis, for kidney disease were presented at ADA 2026. Study data, including real-world analysis, for kidney disease were presented at ADA 2026. Diabetes is the leading cause of kidney failure globally, accounting for nearly half of all chronic kidney disease (CKD) cases. Credit: crystal light / Shutterstock.com At this year’s American Diabetes Association (ADA) congress, while obesity and diabetes treatments took the limelight, there were sessions focused on kidney disease. This included real-world analysis of contributors to metabolic dysfunction-associated kidney diseases and insulin delivery. Chronic Kidney Disease (CKD) induced Hyperparathyroidism (HPT), Hyp... Reports Chronic Kidney Disease-Anemia…
Source: Clinical Trials Arena